PatientFi® Announces Study Partnership with Allergan
May 15 2019 - 6:00AM
Business Wire
Commercial Study Will Measure Impact of Increasing Access and
Affordability of Aesthetic Procedures
PatientFi, LLC, a leading financial technology company that
partners with medical practices to offer patients accessible
financing plans for elective procedures, is pleased to announce its
partnership with Allergan plc on a year-long market research study
to examine the impact of financing plans on patients’ accessibility
to aesthetic procedures.
PatientFi has designed a new patient financing program that
aligns practice staff to help more patients finance procedures such
as breast augmentation, mommy makeovers, and surgical facial
rejuvenation. As such, PatientFi is uniquely situated to study
patient decision-making factors, including perceived value and
affordability.
“PatientFi is excited to partner with Allergan, a world leader
in medical aesthetics, and together help gain an understanding of
the growth potential of this market by identifying the key
financial barriers patients face when considering aesthetic
procedures,” says Dr. Louis Bucky, Chairman, PatientFi, LLC. “The
rate of innovation in patient financing has not kept pace with the
clinical developments of medical aesthetics. We look forward to the
results of this market research study.”
Founded by healthcare industry veterans Scott Jorgensen and Todd
Watts, PatientFi is solving a number of problems with the patient
financing industry today by reducing expensive merchant processing
fees and offering patient-friendly financing options delivered via
a proprietary, instantaneous credit application and decision
process that provides personalized payment plans tailored to each
aesthetic patient’s profile and budget.
Allergan commissioned this patient study through PatientFi’s
platform because of its innovative approach to increasing access
and affordability for patients across the broadest offering of
aesthetic procedures. Allergan and PatientFi plan to present their
findings in Spring 2020.
About PatientFi®
Based in Irvine, California, PatientFi, LLC is a leading
financial technology company that partners with medical practices
to offer patients accessible financing plans for elective
procedures. The PatientFi platform increases patients’ access to
and affordability of aesthetic services and procedures by
delivering high approval rates via monthly payment plan packages
with instant approvals. With PatientFi, medical practices can now
better target and qualify patient leads prior to consultation,
increasing the practice’s overall efficiency, patient acceptance
rates and profitability.
About Allergan plc
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a
global pharmaceutical leader focused on developing, manufacturing
and commercializing branded pharmaceutical, device, biologic,
surgical and regenerative medicine products for patients around the
world. Allergan markets a portfolio of leading brands and
best-in-class products primarily focused on four key therapeutic
areas including medical aesthetics, eye care, central nervous
system and gastroenterology. As part of its approach to delivering
innovation for better patient care, Allergan has built one of the
broadest pharmaceutical and device research and development
pipelines in the industry. With colleagues and commercial
operations located in approximately 100 countries, Allergan is
committed to working with physicians, healthcare providers and
patients to deliver innovative and meaningful treatments that help
people around the world live longer, healthier lives every day.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190515005308/en/
PatientFi Media Contact:Shannon Johnson(818)
721-6801Email: shannon@patientfi.com
Allergan Media Contact:Amy Rose(862) 289-3072Email:
rose_amy@allergan.com
Lisa Brown(862) 261-7320Email: brown_lisa@allergan.com
Allergan (NYSE:AGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Allergan (NYSE:AGN)
Historical Stock Chart
From Apr 2023 to Apr 2024